Search research articles
Contact Us
Filters
Showing results (81-90 of 176) with videos related to
Page
of 18
Sort By:
JAMA Oncology
|
April 8, 2021
Assessment of a Contralateral Esophagus-Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation: A Phase 1 Nonrandomized Clinical Trial
Sophia C Kamran, Beow Y Yeap, Christine A Ulysse, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2013
Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial
Shannon M MacDonald, Sagar A Patel, Shea Hickey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 18, 2014
Proton radiation therapy for the treatment of retinoblastoma
Kent W Mouw, Roshan V Sethi, Beow Y Yeap, et al.
The American Journal of Surgical Pathology
|
October 26, 2012
Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis
Maristela L Onozato, Alexandra E Kovach, Beow Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 16, 2007
Double unrelated reduced-intensity umbilical cord blood transplantation in adults
Karen K Ballen, Thomas R Spitzer, Beow Y Yeap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2015
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib
Justin F Gainor, Daniel S W Tan, Tomasso De Pas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer
Ibiayi Dagogo-Jack, Pablo Martinez, Beow Y Yeap, et al.
Breast Cancer Research and Treatment
|
August 21, 2021
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations
Jing Xu, Tanya E Keenan, Beth Overmoyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer
Pasi A Jänne, Joachim von Pawel, Roger B Cohen, et al.
JTO Clinical and Research Reports
|
March 18, 2026
Brief Report: Androgen Receptor Expression Is Associated With Male Predominance in Thymic Neuroendocrine Neoplasms
Christopher S Nabel, Chad B Sussman, Charles A Whittaker, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 176) with videos related to
Sort By:
Page
of 18
JAMA Oncology
|
April 8, 2021
Assessment of a Contralateral Esophagus-Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation: A Phase 1 Nonrandomized Clinical Trial
Sophia C Kamran, Beow Y Yeap, Christine A Ulysse, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2013
Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial
Shannon M MacDonald, Sagar A Patel, Shea Hickey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 18, 2014
Proton radiation therapy for the treatment of retinoblastoma
Kent W Mouw, Roshan V Sethi, Beow Y Yeap, et al.
The American Journal of Surgical Pathology
|
October 26, 2012
Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis
Maristela L Onozato, Alexandra E Kovach, Beow Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 16, 2007
Double unrelated reduced-intensity umbilical cord blood transplantation in adults
Karen K Ballen, Thomas R Spitzer, Beow Y Yeap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2015
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib
Justin F Gainor, Daniel S W Tan, Tomasso De Pas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer
Ibiayi Dagogo-Jack, Pablo Martinez, Beow Y Yeap, et al.
Breast Cancer Research and Treatment
|
August 21, 2021
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations
Jing Xu, Tanya E Keenan, Beth Overmoyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer
Pasi A Jänne, Joachim von Pawel, Roger B Cohen, et al.
JTO Clinical and Research Reports
|
March 18, 2026
Brief Report: Androgen Receptor Expression Is Associated With Male Predominance in Thymic Neuroendocrine Neoplasms
Christopher S Nabel, Chad B Sussman, Charles A Whittaker, et al.
Page
of 18